Margret Leosdottir on Statin–Ezetimibe Algorithm Dramatically Improving Post-MI LDL-C Outcomes
Margret Leosdottir, Senior cardiology consultant at Skane University Hospital, shared on LinkedIn:
”At Skåne University Hospital in Malmö, in November 2022 we launched an algorithm to support our CCU doctors to prescribe lipid-lowering therapy during ACS hospitalization, focused on increasing the use of ezetimibe for patients not expected to reach goal on high-dose atorvastatin alone.
The algorithm was inspired by prior work from France under the lead of Prof François Schiele.
In just a couple of months, at our hospital the proportion of patients reaching LDL-C goal at 2-months post-MI increased from 30% to 55%.
This increase has remained since, with approximately 65% of our patients now at goal at one-year post-MI
Today we launch a new version of the algorithm, switching primary choice of high-intensity statin to rosuvastatin and further adapting recommendations to the 2025 European Society of Cardiology and European Atherosclerosis Society Lipid GL update.
Failure to implement evidence-based medicine is a major cause of concern in today´s healthcare.
Often simple measures like these can carry us a long way, improving prognosis for our patients and making better use of limited healthcare resources.
The example also shows the usefulness of national registries like SWEDEHEART to track progress and benchmark quality improvement efforts at your clinic
With Emil Hagström and Jessica Schubert.”

Stay updated with Hemostasis Today.
-
Feb 27, 2026, 18:30Sanjeev Saksena: From Isolated Case Reports to Clinical Evidence for Post-Ablation Myocardial Ischemia
-
Feb 27, 2026, 18:21Priya Prasad: Can Money Buy Blood?
-
Feb 27, 2026, 18:19Trulee Cardona: Hemophilia Care in Uzbekistan and Why It Matters
-
Feb 27, 2026, 18:19Bartosz Hudzik: Do Elevated Lipoprotein(a) Levels Predict Long-Term Cardiovascular Risk in Otherwise Healthy Women?
-
Feb 27, 2026, 18:14Mohamed Sikkander Abdul Razak: Factor XIa Inhibitors Show Promise With Lower Bleeding Risk
-
Feb 27, 2026, 18:09Hariom Rajput: Early Recognition and Prevention of Deep Vein Thrombosis
-
Feb 27, 2026, 18:08Karen Fahey: What If the Blood Products You Rely On Weren’t Safe?
-
Feb 27, 2026, 17:46Perla Bandini: Whole-Exome Sequencing Unveils Suspected Primary Hemostasis Disorders
-
Feb 27, 2026, 17:44Ekaterina Balaian: Exploring Fostamatinib Use in APS Patients with Thrombocytopenia